A new classification of clinical findings and treatment options of SARS-CoV-2 infection in children from China

Abstract

Since December2019, cases of SARS-CoV-2 coronavirus infection have been reported in Wuhan, Hubei province, and the epidemic continues to spread. SARS-CoV-2 infections in children seem to progress more mild and slowly as compared to adult courses with severe and some times fatal outcome. Severe or fatal cases in children are yet not described supposing any molecular difference in viral-receptor binding between spike protein and angiotensin II receptor. This manuscript presents a first and completely new classification of clinical findings and treatment options in children infected with SARS-CoV-19 virus.